Cipla's Albuterol Sulfate ANDA219409 Receives FDA Approval Status
Cipla's application for Albuterol Sulfate (ANDA219409) has received an approval status of AP from the FDA.
Therapeutic Area
Therapeutic area intelligence for Bronchodilator with 6 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Nephron's ANDA for Levalbuterol Hydrochloride has received an approval status (AP) from the FDA.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.